KLOW peptide blend is administered by injection through either of the two routes- subcutaneous or (preferably) intramuscular, with the upper arm, thigh or abdomen being the common injection sites
Any claim of proven human efficacy for systemic GHK-Cu is not supported by the published literature and should be treated with caution
Long-term clinical trials are needed to assess the safety and efficacy of these interventions in different patient populations and stages of neurodegenerative diseases
BioBlue Fitness did not respond to a request for comment but deleted all messages and discussions in its Telegram channel, telling customers it had changed settings
Community-reported (anecdotal): headache, brain fog or mental fatigue, irritability, anxiety, nausea or other GI upset, appetite and sleep changes, blood-pressure changes, and skin reactions with transdermal-DMSO use